| Literature: Camilleri, M., et al.: Lancet, 355, 1035 (2000), Nestorov, I., et al.: Drug Metab. Dispos., 30, 276 (2002), Lewis, D., et al.: Drug Metab. Rev., 35, 1 (2003), Tang, H., et al.: J. Pharm. Sci., 95, 1783 (2006), Gleeson, M., et al.: J. Med. Chem., 50, 101 (2007) |
| Application: 6-hydroxy Alosetron HCl: 2,3,4,5-tetrahydro-5-methyl-2-[(5-methyl-1H-imidazo1-4-yl)methyl]-1H-pyrido[4,3-b]-6-hydroxyindol-l-one, mono hydrochloride useful as reference Impurity standard. Note: The compounds strictly supplied only for R&D /AR&D purpose, not for human/animal consumption. |